193 related articles for article (PubMed ID: 29459010)
21. A three plasma microRNA signature for papillary thyroid carcinoma diagnosis in Chinese patients.
Wang Z; Lv J; Zou X; Huang Z; Zhang H; Liu Q; Jiang L; Zhou X; Zhu W
Gene; 2019 Apr; 693():37-45. PubMed ID: 30684524
[TBL] [Abstract][Full Text] [Related]
22. A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis.
Zhou X; Wen W; Shan X; Zhu W; Xu J; Guo R; Cheng W; Wang F; Qi LW; Chen Y; Huang Z; Wang T; Zhu D; Liu P; Shu Y
Oncotarget; 2017 Jan; 8(4):6513-6525. PubMed ID: 28036284
[TBL] [Abstract][Full Text] [Related]
23. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.
Ghaedi H; Mozaffari MAN; Salehi Z; Ghasemi H; Zadian SS; Alipoor S; Hadianpour S; Alipoor B
Gene; 2019 Mar; 687():135-142. PubMed ID: 30447342
[TBL] [Abstract][Full Text] [Related]
24. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
25. Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy.
Zhang M; Duan ZY; Zhang QY; Xu XG; Zhang Y; Wang P; Duan SW; Wu J; Chen XM; Cai GY
Sci Rep; 2023 Apr; 13(1):6048. PubMed ID: 37055445
[TBL] [Abstract][Full Text] [Related]
26. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
[TBL] [Abstract][Full Text] [Related]
27. Circulating plasma microRNA signature for the diagnosis of cervical cancer.
Ma G; Song G; Zou X; Shan X; Liu Q; Xia T; Zhou X; Zhu W
Cancer Biomark; 2019; 26(4):491-500. PubMed ID: 31658043
[TBL] [Abstract][Full Text] [Related]
28. Serum microRNA expression profiling revealing potential diagnostic biomarkers for lung adenocarcinoma.
Shan X; Zhang L; Zhu DX; Zhou X; Zhang H; Liu QX; Tang JW; Wen W; Wang TS; Zhu W; Liu P
Chin Med J (Engl); 2020 Nov; 133(21):2532-2542. PubMed ID: 32947363
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of urinary exosomal microRNAs in IgA nephropathy.
Min QH; Chen XM; Zou YQ; Zhang J; Li J; Wang Y; Li SQ; Gao QF; Sun F; Liu J; Xu YM; Lin J; Huang LF; Huang B; Wang XZ
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28383146
[TBL] [Abstract][Full Text] [Related]
30. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
31. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
32. Identification of four plasma microRNAs as potential biomarkers in the diagnosis of male lung squamous cell carcinoma patients in China.
Shan X; Zhang H; Zhang L; Zhou X; Wang T; Zhang J; Shu Y; Zhu W; Wen W; Liu P
Cancer Med; 2018 Jun; 7(6):2370-2381. PubMed ID: 29673101
[TBL] [Abstract][Full Text] [Related]
33. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
[TBL] [Abstract][Full Text] [Related]
34. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
35. Five serum microRNAs for detection and predicting of ovarian cancer.
Wang W; Wu LR; Li C; Zhou X; Liu P; Jia X; Chen Y; Zhu W
Eur J Obstet Gynecol Reprod Biol X; 2019 Jul; 3():100017. PubMed ID: 31404211
[TBL] [Abstract][Full Text] [Related]
36. MiR-28-3p as a potential plasma marker in diagnosis of pulmonary embolism.
Zhou X; Wen W; Shan X; Qian J; Li H; Jiang T; Wang W; Cheng W; Wang F; Qi L; Ding Y; Liu P; Zhu W; Chen Y
Thromb Res; 2016 Feb; 138():91-95. PubMed ID: 26702486
[TBL] [Abstract][Full Text] [Related]
37. Use of a Four-miRNA Panel as a Biomarker for the Diagnosis of Stomach Adenocarcinoma.
Chen X; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y
Dis Markers; 2020; 2020():8880937. PubMed ID: 33224315
[TBL] [Abstract][Full Text] [Related]
38. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
39. miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy.
Hennino MF; Buob D; Van der Hauwaert C; Gnemmi V; Jomaa Z; Pottier N; Savary G; Drumez E; Noël C; Cauffiez C; Glowacki F
Sci Rep; 2016 Jun; 6():27209. PubMed ID: 27264483
[TBL] [Abstract][Full Text] [Related]
40. Circulating MicroRNA-26a in Plasma and Its Potential Diagnostic Value in Gastric Cancer.
Qiu X; Zhang J; Shi W; Liu S; Kang M; Chu H; Wu D; Tong N; Gong W; Tao G; Zhao Q; Qiang F; Zhu H; Wu Q; Wang M; Zhang Z
PLoS One; 2016; 11(3):e0151345. PubMed ID: 27010210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
